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Background: Patients with diabetes have an increased risk of venous thromboembolism (VTE).
Methods: We studied diabetic patients in the population-based Worcester VTE Study of 2,488 consecutive patients with validated VTE.
Results: Of 2,488 VTE patients, 476 (19.1%) had a clinical history of diabetes (Table). Thromboprophylaxis was omitted in more than one-third 
of diabetic patients who had been hospitalized for non-VTE-related illness or had undergone major surgery within the three months prior to 
VTE. Diabetic patients were more likely to have a complicated course after VTE. Diabetic patients were more likely to suffer recurrent deep vein 
thrombosis (DVT) (14.9% vs. 10.7%) and long-term major bleeding complications (16.4% vs. 11.7%) than non-diabetic patients (all p=0.01). 
Diabetes was associated with a significant increase in recurrent DVT (adjusted odds ratio 1.74; 95% confidence interval 1.21-2.51). Aspirin therapy 
at discharge (adjusted odds ratio 1.59; 95% confidence interval 1.1-2.3) and chronic kidney disease (adjusted odds ratio 2.19; 95% confidence 
interval 1.44-3.35) were independent predictors of long-term major bleeding.
Conclusion: Diabetic patients who subsequently developed VTE were more likely to suffer a complicated clinical course after developing VTE. 
Diabetes was an independent predictor of recurrent DVT. We observed a low rate of thromboprophylaxis in diabetic patients. Further studies should 
focus on VTE prevention in this vulnerable patient population.
 
